Multiple micro-bypass stents lower IOP

Article

Multiple micro-bypass stents with concurrent cataract surgery lowers IOP to less than 15 mmHg in patients with open-angle glaucoma (OAG) and cataract.

Multiple micro-bypass stents with concurrent cataract surgery lowers IOP to less than 15 mmHg in patients with open-angle glaucoma (OAG) and cataract.

A team led by Dr Graham W. Belovay, at a private practice, Mississauga, Ontario, Canada, completed a comparative case series on 53 eyes of 47 patients with OAG. Of the eyes studied, 28 had two stents implanted and 25 had three stents implanted.

Each patient was followed up for one year and efficacy measures included intraocular pressure (IOP) and topical ocular hypotensive medication use. The safety assessment consisted of complications and corrected distance visual acuity (CDVA).

Overall mean one-year postoperative IOP was 14.3 mmHg, which was significantly lower than the overall preoperative IOP. Target IOP was achieved in a high proportion of eyes and there were 83% of eyes who experienced a reduction in topical ocular hypotensive medication one-year postoperatively.

The three-stent group required significantly fewer medications than the two-stent group at one year.

The abstract can be found in the Journal of Cataract and Refractive Surgery.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.